These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 6602819

  • 21. High-resolution PET studies in Alzheimer's disease.
    Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI.
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [Abstract] [Full Text] [Related]

  • 22. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
    Koss E, Friedland RP, Ober BA, Jagust WJ.
    Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
    [Abstract] [Full Text] [Related]

  • 23. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE, Metter EJ, Riege WH, Hawkins RA.
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract] [Full Text] [Related]

  • 24. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 25. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.
    Nordberg A, Lilja A, Lundqvist H, Hartvig P, Amberla K, Viitanen M, Warpman U, Johansson M, Hellström-Lindahl E, Bjurling P.
    Neurobiol Aging; 1992 Feb; 13(6):747-58. PubMed ID: 1491741
    [Abstract] [Full Text] [Related]

  • 26. 18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
    McGeer EG, Peppard RP, McGeer PL, Tuokko H, Crockett D, Parks R, Akiyama H, Calne DB, Beattie BL, Harrop R.
    Can J Neurol Sci; 1990 Feb; 17(1):1-11. PubMed ID: 2311010
    [Abstract] [Full Text] [Related]

  • 27. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.
    Di Chiro G.
    Invest Radiol; 1987 May; 22(5):360-71. PubMed ID: 3496318
    [No Abstract] [Full Text] [Related]

  • 28. Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography.
    Blin J, Piercey MF, Giuffra ME, Mouradian MM, Chase TN.
    J Neurol Sci; 1994 May; 123(1-2):44-51. PubMed ID: 8064320
    [Abstract] [Full Text] [Related]

  • 29. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K.
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [Abstract] [Full Text] [Related]

  • 30. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
    Kumar A, Schapiro MB, Haxby JV, Grady CL, Friedland RP.
    J Psychiatr Res; 1990 Jun; 24(2):97-109. PubMed ID: 2213642
    [Abstract] [Full Text] [Related]

  • 31. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
    Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, Cedarbaum J, Greene P, Fahn S, Rottenberg DA.
    Mov Disord; 1990 Jun; 5(3):203-13. PubMed ID: 2117706
    [Abstract] [Full Text] [Related]

  • 32. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J, Peppard R, Calne DB.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May 25; 49(5):643-56. PubMed ID: 2798056
    [Abstract] [Full Text] [Related]

  • 33. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.
    Kuhl DE, Metter EJ, Riege WH, Phelps ME.
    J Cereb Blood Flow Metab; 1982 May 25; 2(2):163-71. PubMed ID: 6978885
    [Abstract] [Full Text] [Related]

  • 34. [A longitudinal study of CMRGlu in dementia of Alzheimer type].
    Kuwabara Y, Ichiya Y, Ichimiya A, Sasaki M, Akashi Y, Yoshida T, Fukumura T, Masuda K.
    Kaku Igaku; 1994 Oct 25; 31(10):1255-60. PubMed ID: 7807730
    [Abstract] [Full Text] [Related]

  • 35. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
    González RG, Fischman AJ, Guimaraes AR, Carr CA, Stern CE, Halpern EF, Growdon JH, Rosen BR.
    AJNR Am J Neuroradiol; 1995 Oct 25; 16(9):1763-70. PubMed ID: 8693972
    [Abstract] [Full Text] [Related]

  • 36. Greater left cerebral hemispheric metabolism in bulimia assessed by positron emission tomography.
    Wu JC, Hagman J, Buchsbaum MS, Blinder B, Derrfler M, Tai WY, Hazlett E, Sicotte N.
    Am J Psychiatry; 1990 Mar 25; 147(3):309-12. PubMed ID: 2309947
    [Abstract] [Full Text] [Related]

  • 37. Alzheimer's dementia.
    Chase TN, Tamminga CA.
    Am J Psychiatry; 1995 Aug 25; 152(8):1110. PubMed ID: 7625456
    [No Abstract] [Full Text] [Related]

  • 38. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 25; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 39. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E.
    J Nucl Med; 1998 Nov 25; 39(11):1875-8. PubMed ID: 9829574
    [Abstract] [Full Text] [Related]

  • 40. The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory.
    Staffaroni AM, Melrose RJ, Leskin LP, Riskin-Jones H, Harwood D, Mandelkern M, Sultzer DL.
    J Clin Exp Neuropsychol; 2017 Sep 25; 39(7):682-693. PubMed ID: 27876444
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.